These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 13994646)

  • 1. Tissue copper levels in Chinese patients with Wilson's disease.
    TU JB; BLACKWELL RQ; HOU TY
    Neurology; 1963 Feb; 13():155-9. PubMed ID: 13994646
    [No Abstract]   [Full Text] [Related]  

  • 2. TREATMENT OF HEPATOLENTICULAR DEGENERATION (WILSON'S DISEASE) IN THE ASYMPTOMATIC STAGE.
    TU JB; COOPER WC; BLACKWELL RQ; HOU TY
    Neurology; 1965 Apr; 15():402-8. PubMed ID: 14280605
    [No Abstract]   [Full Text] [Related]  

  • 3. STUDY OF WILSON'S DISEASE IN TAIWAN.
    TU JB; HUNG TP; LIN TY; BLACKWELL RQ; WATTEN RH; COOPER WC
    J Philipp Med Assoc; 1963 Sep; 39():739-42. PubMed ID: 14073714
    [No Abstract]   [Full Text] [Related]  

  • 4. COPPER BALANCE STUDIES DURING THE TREATMENT OF PATIENTS WITH WILSON'S DISEASE.
    TU JB; BLACKWELL RQ; WATTEN RH
    Metabolism; 1965 Jun; 14():653-66. PubMed ID: 14293521
    [No Abstract]   [Full Text] [Related]  

  • 5. A GENETIC, BIOCHEMICAL AND CLINICAL STUDY OF WILSON'S DISEASE AMONG CHINESE IN TAIWAN.
    TU JB
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1963; 4():81-104. PubMed ID: 14049950
    [No Abstract]   [Full Text] [Related]  

  • 6. [Wilson's disease or hepatolenticular degeneration].
    Mensing B; Nowak A; Zweifel S; Terracciano L; Bernsmeier C; Filipowicz Sinnreich M
    Ther Umsch; 2018 Nov; 75(4):241-248. PubMed ID: 30468117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Physiopathology of hepatolenticular degeneration (Wilson's disease)].
    Willvonseder R
    Wien Z Inn Med; 1973; 54(11-12):544-58. PubMed ID: 4804125
    [No Abstract]   [Full Text] [Related]  

  • 9. Wilson's disease and other neurological copper disorders.
    Bandmann O; Weiss KH; Kaler SG
    Lancet Neurol; 2015 Jan; 14(1):103-13. PubMed ID: 25496901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The link between copper and Wilson's disease.
    Purchase R
    Sci Prog; 2013; 96(Pt 3):213-23. PubMed ID: 24244969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wilson's disease (hepatolenticular degeneration) of late adult onset: report of case.
    Fitzgerald MA; Gross JB; Goldstein NP; Wahner HW; McCall JT
    Mayo Clin Proc; 1975 Aug; 50(8):438-42. PubMed ID: 1152537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on copper metabolism. XXIX. A critical analysis of serum copper and ceruloplasmin concentrations in normal subjects, patients with Wilson's disease and relatives of patients with Wilson's disease.
    CARTWRIGHT GE; MARKOWITZ H; SHIELDS GS; WINTROBE MM
    Am J Med; 1960 Apr; 28():555-63. PubMed ID: 13808058
    [No Abstract]   [Full Text] [Related]  

  • 13. Defective biliary copper excretion in Wilson's disease: the role of caeruloplasmin.
    Davis W; Chowrimootoo GF; Seymour CA
    Eur J Clin Invest; 1996 Oct; 26(10):893-901. PubMed ID: 8911863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cultured skin fibroblasts: useful for diagnosis of Wilson's disease?
    Van den Berg GJ; Van den Hamer CJ; Meijer RJ; Hoogenraad TU
    J Inherit Metab Dis; 1989; 12(1):64-71. PubMed ID: 2501585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of two novel mutations in the ATP7B gene that cause Wilson's disease.
    Zhu HW; Tao ZB; Su G; Jin QY; Zhao LT; Zhu JR; Yan J; Yu TY; Ding JX; Li YM
    World J Pediatr; 2017 Aug; 13(4):387-391. PubMed ID: 28856630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Wilson's disease].
    Moilanen V; Mäkisalo H
    Duodecim; 2010; 126(6):635-42. PubMed ID: 20597314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modern views on the pathogenesis of Wilson's disease].
    Bertrand E; Lechowicz W; Szpak GM; Lewandowska E; Członkowska A; Dymecki J
    Neurol Neurochir Pol; 1998; 32(2):367-77. PubMed ID: 9760555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma and erythrocyte copper, zinc, manganese and magnesium concentrations in Wilson's disease.
    Goto I; Kawano Y; Tsuchiya T; Tamagawa Y; Kuroiwa Y
    Clin Neurol Neurosurg; 1986; 88(3):193-6. PubMed ID: 3780108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copper removal strategies for Wilson's disease crisis in the ICU.
    Reynolds HV; Talekar CR; Bellapart J; Leggett BA; Boots RJ
    Anaesth Intensive Care; 2014 Mar; 42(2):253-7. PubMed ID: 24580393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers for diagnosis of Wilson's disease.
    Ryan A; Nevitt SJ; Tuohy O; Cook P
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31743430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.